Peter A. Lando

Monoclonal antibody-superantigen fusion proteins: tumor-specific agents for T-cell-based tumor therapy.

Mikael Dohlsten, Lars Abrahmsén, P. Björk et al. · Proceedings of the National Academy of Sciences · 1994 · 128 citations · Full text

Monoclonal antibody-targeted superantigens: a different class of anti-tumor agents.

Mikael Dohlsten, Gunnar Hedlund, Eva Åkerblom et al. · Proceedings of the National Academy of Sciences · 1991 · 100 citations · Full text

Cancer Immunosurveillance, Monoclonal Antibody-targeted Superantigens, Immunology +12

Targeting of human cytotoxic T lymphocytes to MHC class II-expressing cells by staphylococcal enterotoxins.

Mikael Dohlsten, Peter A. Lando, Gunnar Hedlund et al. · PubMed · 1990 · 65 citations

Microbial Pathogens, Immunology, Immunologic Mechanism +17

Antibody‐targeted superantigen therapy induces tumor‐infiltrating lymphocytes, excessive cytokine production, and apoptosis in human colon carcinoma

Mark J. Litton, Mikael Dohlsten, Peter A. Lando et al. · European Journal of Immunology · 1996 · 64 citations

Therapy of human non-small-cell lung carcinoma using antibody targeting of a modified superantigen

G. Forsberg, Lennart Ohlsson, Thomas Brodin et al. · British Journal of Cancer · 2001 · 63 citations · Full text